Skip to content
  • support@editverse.com
  • Home
  • Publication Support Services
    • Publication Support Services (All)
    • Plagiarism Correction Services
    • Response to reviewers (Response letter only)
    • Word-count Reduction Services
    • Reference Selection
    • Statistical Review
    • Brief Literature Review
    • Scientific Journal Selection Services
    • Brief Literature Review
    • Pre-submission Review Service
    • Referee Recommendations
    • Reference Selection
    • Statistical Review & Analysis Services
    • Response to reviewers (Response letter only)
  • Manuscript Writing Services
    • Manuscript Writing Services ( All)
    • Just Data Service
    • Material and Methods Writing
    • Result and Discussion Writing
    • Abstract Writing Services
    • Introduction writing
    • Case-Report Novelty Statement
    • Cover Letter Writing Services
    • Plagiarism Correction Services
    • Result and Discussion Writing
    • Poster Presentation (Conference/Seminar/Symposium)
    • Re-Writing Package
    • Plagiarism Check and Correction
    • Video Abstract/ Summary
  • Editing & Translation
    • Manuscript Editing Services(All)
    • Substantive Editing
    • Copyediting
    • Proofreading
    • Word-count Reduction Services
    • Translation
      • Japanese to English
      • Korean to English
      • Mandarin to English
      • Turkish to English
      • Portuguese to English
      • Spanish to English
      • German to English
  • R&D Consultancy
    • Clinical Trial Design
    • Literature Review
    • Experiment Design
    • Meta-analysis
    • Data Interpretation
    • Experiment to Publication Consultancy
    • Research Grant Writing Support
  • About Us

日本人のがん研究 (Cancer Research in Japanese)

#がんゲノム #AI支援 #治療選択

日本人のがんゲノム医療における人工知能治療選択支援の精度評価

がんゲノム医療における治療選択をAIが支援。日本人患者のゲノムデータを基に、#がんゲノム #AI支援 #治療選択 の精度と有効性を評価し、個別化医療の実現に向けた最新の研究成果を報告

Category : トップジャーナル攻略法 がんゲノム医療 (Cancer Genomic Medicine), がん治療最新技術 (Latest Technologies in Cancer Treatment), ガイドライン遵守 (Compliance with Guidelines), ゲノム医療の未来 (Future of Genomic Medicine), 人工知能治療 (Artificial Intelligence Therapy), 医療技術革新 (Medical Technology Innovation), 日本人のがん研究 (Cancer Research in Japanese), 治療選択支援システム (Therapeutic Decision Support System), 精度評価 (Accuracy Evaluation) Read More

Product categories

  • Consultancy Services (3)
  • Editing Services (5)
  • Just Data Services (1)
  • Publication Support Services (36)
  • Translation Services (1)
  • Writing Services (28)

SAFE | SECURE | Ethical Website

Editverse is a completely secure website.  All your information is protected and will never be shared with a third party.  We are protected by SSL, Mcafee Secure and Google’s reCAPTCHA.  We are committed to following COPE guidelines in all of our services.

SSL Secure

McAfee Secure Website

Every McAfee SECURE certified site is tested and certified to be free of malware, viruses, phishing attacks, and other things that can harm you and your computer.
McAfee SECURE certified site

Google reCAPTCHA

Career at Editverse

We are hiring. Please send your CV.

Full Time: ca*****@*******se.com

Freelancer: fr*********@*******se.com

What we need!

Please submit your CV if you have any of follwing qualifications and a passion for research.

PhD|MS|MD|MCH|DNB|MSc

For Technical Editing & writing:

Publication in 5+ impact factor Journal and reviewing experience in SCI/SCIE  indexed journals is essential.

Search

Your Orders

If you come across any outdated/incorrect information in this website, kindly email us at co*****@*******se.com to request updates.

Contact Us (US Office)

  • Editverse (Global Operations) |539 W. Commerce St Dallas TX 75208 USA
  • support@editverse.com

联系我们

  • 中国 商业 | China Operations| 要求报价 | hello.china@editverse.com 你可以用中文发邮件给我们

お問い合わせ

  • 日本 事業 | Japan Operations | お見積り依頼 | hello.japan@editverse.com 日本語でメールできます。

Asia Operations

  • Registered Office: Neucite Research Private Limited, Old Diwani ETAWAH Etawa UP 206001 (CIN) U73100UP2019OPC112451

Security | Privacy

Refund Policy 

Privacy Policy

Non-Disclosure Agreement

Publication Ethics

 

Powered by

Editverse is a proud innovation venture of Neucite Research – An R&D Consultancy and Innovation Management Company.

© 2025 Editverse | Designed by: Theme Freesia | Powered by: WordPress
We use cookies on our website to give you the most relevant experience. If you continue to use this site we will assume that you are happy with it.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT